Improve Your Rank!

View Profile

Julia A Haller

Peer Reviewed Papers, Books, Chapters
Year Title Citation Authors
1. 2009 Effects of dilation on electronic-ETDRS visual acuity in diabetic patients Invest Ophthalmol Vis Sci 2009;50(4):1580-1584
2. 2009 Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome Am J Ophthalmol E-Pub. Mar. 2009.
3. 2009 Evaluation of the safety and performance of an applicator for a novel intravitreal dexamethasone drug delivery system for the treatment of macular edema Retina 2009;29(1):46-51.
4. 2009 An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedema. Br J Ophthalmol 2009;93(2): 144-149
5. 2009 Observational study of the development of diabetic macular edema following panretinal (Scatter) photocoagulation given in 1 or 4 sittings. Arch Ophthalmol 2009;127(2):132-140
6. 2009 Comparison of optical coherence tomography in diabetic macular edema, with and without reading center manual grading from a clinical trials perspective. Invest Ophthalmol Vis Sci 2009;50(2):560-566
7. 2008 Arron JR. Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator Mol Ther 2008;16(4):791-799.
8. 2008 Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy Am J Ophthalmol 2008;145(5):894-901.
9. 2008 The National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) Project Invest Ophthalmol Vis Sci 2008;49(10):4340-4346
10. 2008 Diabetic macular edema: what is focal and what is diffuse? Am J Ophthalmol 2008;146(5):649-655
11. 2008 Comparison of time-domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema Invest Ophthalmol Vis Sci 2008;49:1745-1752
12. 2008 Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases other than age-related macular degeneration. Am J Ophthalmol 2008;145(2):257-266
13. 2008 Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology 2008;115:1366-1371
14. 2008 Regression of a subfoveal choroidal metastasis of colorectal carcinoma after intravitreal bevacizumab. Arch Ophthalmol 2008;126:1311-1313
15. 2008 Sutured sulcus fixation of an anteriorly dislocated endocapsular intraocular lens. Arch Ophthalmol 2008;126(11):1567-1570.
16. 2007 The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE Clinical Trials Am J Ophthalmol 2007;144:454-456.
17. 2007 Subretinal band: clinicopathologic correlation of a pseudoparasite. Retina Cases & Brief Reports 2007;1(2).
18. 2007 Relationship between Optical Coherence Tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology 2007;114:525-536
19. 2007 Randomized controlled study of intravitreous Dexamethasone Drug Delivery System in patients with persistent macular edema. Arch Ophthalmol 2007;125(3):309-317
20. 2007 Impact of optical coherence tomography on surgical decision making for epiretinal membranes and vitreomacular traction Retina 2007;27:552-556
21. 2007 The relationship of dietary lipid intake and age-related macular degeneration in a case-control study. AREDS Report #20. Arch Ophthalmol 2007;125:671-679
22. 2007 Delayed intraocular foreign body removal without endophthalmitis during Operations Iraqi Freedom and Enduring Freedom Ophthalmology 2007;114(8):1439-1447
23. 2007 Laser scanning imaging for macular disease: a report by the American Academy of Ophthalmology Ophthalmology 2007;114(6):1221-1228.
24. 2007 The relationship of dietary lipid intake and age-related macular degeneration in a case-controlled study Arch Ophthalmol 2007;125(5):671-679
25. 2007 The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study. Arch Ophthalmol 2007;125:1225-1232
26. 2007 Incident choroidal neovascularization in follow eyes of patients with unilateral subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol 2007;125:1323-1330
27. 2007 Comparison of the modified early treatment diabetic retinopathy study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol 2007;125(4):469-480.
28. 2007 Optical coherence tomography findings in persistent diabetic macular edema: the vitreomacular interface Am J Ophthalmol 2007;144(5):747-754.
29. 2007 Comparison of modified-ETDRS and mild macular grid laser photocoagulation strategies for diabetic macular edema Arch Ophthalmol 2007;125:469-480
30. 2007 Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: A pilot study. Ophthalmology 2007;114:1190-1196
31. 2007 Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology 2007;114:1520-1525.
32. 2007 Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial Arch Ophthalmol 2007;125:1460-1469
33. 2007 A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema Ophthalmology 2007;114:1860-1867
34. 2006 Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration Ophthalmology 2006;113:1508-1521
35. 2006 Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials Ophthalmology 2006;113:992-1001
36. 2006 A phase 1 trial of an IV-administered vascular endothelial growth factor trap for treatment in patients with choroidal neovascularization due to age-related macular degeneration Ophthalmology 2006;113:1522-1532
37. 2006 Centrum use and progression of age-related cataract in the age-related eye disease study: a propensity score approach. AREDS Report No. 21. Ophthalmology 2006;113:1264-1270
38. 2006 Clinicopathologic studies of eyes obtained post-mortem from four patients enrolled in the Submacular Surgery Trials: SST Report No. 16. Am J Ophthalmol 2006;141:93-104
39. 2006 Cognitive impairment in the Age-Related Eye Disease Study. AREDS Report No. 16 Arch Ophthalmol 2006;124:537-543
40. 2006 Spontaneous resolution of macular microhole Am J Ophthalmol 2006;141:210-212
41. 2006 Comparison of 2D reconstructions of surgically excised subfoveal choroidal neovascularization with fluorescein angiographic features: SST Report No. 15. Ophthalmology 2006;113:267-279
42. 2006 The impact of optical coherence tomography on surgical decision making in epiretinal membrane and vitreomacular traction Trans Am Ophthalmol Soc 2006;104:161-166.
43. 2006 Complications of sequential keratorefractive and vitreoretinal surgery. J Cataract Refract Surg 2006;32:2146-2148
44. 2006 Ranibizumab for neovascular age-related macular degeneration. NEJM 2006;335:1419-1431
45. 2006 Visual acuity at 10 years in Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) Study eyes Arch Ophthalmol 2006;124:199-202
46. 2006 Risk Factors for Age-Related Macular Degeneration and Choroidal Neovascularization (2nd edition) in Lim JI (ed), Age-Related Macular Degeneration, Marcel Dekker, Inc., New York, 2006.
47. 2006 Vascular endothelial growth factor is a critical stimulus for diabetic macular edema. Am J Ophthalmol 2006;142:961-969
48. 2006 Diurnal variation in retinal thickening measurement by Optical Coherence Tomography in center-involved diabetic macular edema. Arch Ophthalmol 2006;124:1701-1707
49. 2005 Guidelines for interpreting retinal photographs and coding findings in the Submacular Surgery Trials (SST). SST Report No. 8. Retina 2005;25:253-268
50. 2005 Vitreoretinal biopsy in the management of posterior segment inflammatory disease. Batlle IR (ed) To the Macula and Beyond, The Hague, The Netherlands, 2005
51. 2005 Effect of order of administration of health-related quality of life interview instruments on responses. SST Report No. 3. Qual Life Res 2005;14:493-500
52. 2005 A simplified severity scale for age-related macular degeneration. AREDS Report No. 18. Arch Ophthalmol 2005;123:1570-1574.
53. 2005 The age-related eye disease study severity scale for age-related macular degeneration. AREDS Report No. 17 Arch Ophthalmol 2005;123:1484-1498
54. 2005 Enhanced efficacy associated with early treatment of neovascular age-related macular degeneration with pegaptanib sodium: an exploratory analysis. Retina 2005;25:815-827
55. 2005 Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity. AREDS Report No. 14 Arch Ophthalmol 2005;123:1207-1214.
56. 2005 Histopathological and ultrasound features of surgically excised subfoveal choroidal neovascular lesions. SST Report No. 7. Arch Ophthalmol 2005;123:914-921
57. 2005 Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration. Ophthalmology 2005;112:1048-1053
58. 2005 Evaluation of the traveling vision examiner program of the Submacular Surgery Trials Pilot Study Ophthalmic Epidemiol 2005;12:47-57
59. 2005 Persistent diabetic macular edema is associated with elevated hemoglobin A1c. Am J Ophthalmol 2005;139:620-623
60. 2005 Comparison of retrobulbar and sub-Tenon’s capsule injection of local anesthetic in vitreoretinal surgery Ophthalmology 2005;112:574-579
61. 2005 Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 19. Ophthalmology 2005;112:533-539
62. 2005 15-Year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity Arch Ophthalmol 2005;123:311-318.
63. 2005 Health-and-vision-related quality of life among patients with ocular histoplasmosis or idiopathic choroidal neovascularization at enrollment in a randomized trial of submacular surgery. SST Report No. 5 Arch Ophthalmol 2005;123:78-88
64. 2004 Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study (AREDS). AREDS Report No. 13 Arch Ophthalmol 2004;122:716-726.
65. 2004 Potential public health impact of age-related eye disease study results. AREDS Report No. 11 Arch Ophthalmol 2004;121:1621-1624
66. 2004 Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: quality-of-life findings. SST Report No. 12. Ophthalmology 2004;111:1981-1992
67. 2004 Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: Ophthalmic findings. SST Report No. 11. Ophthalmology 2004;111:1967-1980
68. 2004 Responsiveness of the SF-36 Health Survey to changes in visual acuity among patients with subfoveal choroidal neovascularization. Am J Ophthalmol 2004;137:373-395.
69. 2004 Health and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment of randomized trials of submacular surgery: SST Report No. 4. Am J Ophthalmol 2004;138:91-108
70. 2004 Clinical trial performance of community-based compared with university-based practices: lessons from the Submacular Surgery Trials. SST Report No. 2. Arch Ophthalmol 2004;122:857-863
71. 2004 Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study Am J Ophthalmol 2004;136:454-463.
72. 2004 Single-field fundus photography for diabetic retinopathy screening: a report by the American Academy of Ophthalmology. Ophthalmology 2004;111:1055-1062
73. 2004 Vitreous levels of Pigment Epithelium-Derived Factor (PEDF) and Vascular Endothelial Growth Factor (VEGF): implications for ocular angiogenesis Am J Ophthalmol 2004;137:668-674
74. 2004 Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: quality-of-life findings. SST Report No. 14. Ophthalmology 2004;111:2006-2014
75. 2004 Surgical removal versus observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic. I. Ophthalmic findings from a randomized clinical trial: SST Group H Trial. SST Report No. 9. Arch Ophthalmol 2004;122:1597-1611
76. 2004 Surgical removal versus observation of subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic. II. Quality-of-life findings from a randomized clinical trial: SST Group H Trial. SST report No. 10. Arch Ophthalmol 2004;122:1616-1628
77. 2004 Educational and social competencies at 8 years in children with threshold retinopathy of prematurity Pediatrics 2004;113(4):790-799
78. 2004 Reduction of diabetic macular edema by oral administration of the Kinase Inhibitor PKC412 Invest Ophthalmol Vis Sci 2004;45:922-931
79. 2004 Health-related quality of life at age 10 years in very low-birth-weight children with and without threshold retinopathy of prematurity Arch Ophthalmol 2004;122:1659-1666.
80. 2004 Retinal pigment epithelial abnormalities after internal limiting membrane peeling guided by indocyanine green staining Retina 2004;24:157-160.
81. 2004 Assessment of preference values among patients with subfoveal choroidal neovascularization--the Submacular Surgery Trials Vision Preference Value Scale: SST Report No. 6. Arch Ophthalmol 2004;122:1856-1867.
82. 2004 Impact of antioxidants, zinc, and copper on cognition in the elderly. A randomized, controlled trial Neurology 2004;63: 1705-1707.
83. 2004 Changes in lesion size following submacular surgery for subfoveal choroidal neovascularization in the Submacular Surgery Trials Pilot Study Retina 2004;24:888-899
84. 2004 Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805-2816
85. 2004 Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings. SST Report No. 13. Ophthalmology 2004;111:1993-2006
86. 2003 Risk analysis of prethreshold retinopathy of prematurity Arch Ophthalmol 2003;121(12):1697-1701.
87. 2003 Incidence and management of cataract after retinal detachment repair with silicone oil in immune compromised patients with cytomegalovirus retinitis. Am J Ophthalmol 2003;136:1009-1015.
88. 2003 National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS). AREDS Report No. 10. Arch Ophthalmol 2003;121:211-217
89. 2003 Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration. Phase II study results. Ophthalmology 2003;110:979-986
90. 2003 Surgical management of anterior chamber epithelial cysts. Am J Ophthalmol 2003;135(3):309-313
91. 2003 Combined phacoemulsification, intraocular lens implantation, and vitrectomy for eyes with coexisting cataract and vitreoretinal pathology Am J Ophthalmol 2003;135:291-296.
92. 2003 Intraoperative Ketorolac and eye pain after vitreoretinal surgery: a prospective, randomized, placebo controlled study Retina 2003;23:8-13
93. 2003 Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization. SST Report No. 1 Arch Ophthalmol 2003;121:1513.
94. 2002 Preclinical and phase IA clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration Retina 2002;22:143-152
95. 2002 Macular Translocation Surgery in de Freitas J (ed) Atlas of Macula: Clinic and Surgery, Riomed, Rio de Janeiro, 2002
96. 2002 Surgical Techniques for Macular Hole Treatment Emphasizing Internal Limiting Membrane Peeling in de Freitas J (ed) Atlas of Macula: Clinic and Surgery, Riomed, Rio de Janeiro, 2002
97. 2002 Management of Posterior Segment Complications of Anterior Segment Surgery in Steidl S (ed), Clinical Pathways of Vitreoretinal Diseases, Thieme, New York, 2002
98. 2002 Risk Factors for Age-Related Macular Degeneration and Choroidal Neovascularization in Lim JI (ed), Age-Related Macular Degeneration, Marcel Dekker, Inc., New York, 2002.
99. 2002 Surgical approaches to the management of epithelial cysts. Trans Am Ophthalmol Soc 2002;100:79-84
100. 2002 Outcomes and complications associated with giant retinal tear management using Perfluoro-n-octane Ophthalmology 2002;109:1828-1833
101. 2002 Comparison between retinal thickness analyzer and optical coherence tomography for assessment of foveal thickness in eyes with macular disease Am J Ophthalmol 2002;134: 240-251.
102. 2002 Resolution of epithelial ingrowth in a patient treated with 5-fluorouracil Am J Ophthalmol 2002;133:562-564.
103. 2001 Clinicopathologic findings in eyes with retained perfluoro-n-octane liquid Ophthalmology 2001;108(1): 45-48
104. 2001 Eye pain after modern vitreoretinal surgery: a prospective study in 185 patients. Retina 2001;21:627-632
105. 2001 Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD). Hum Gene Ther 2001;12:2029-2032
106. 2001 Multicenter trial of cryotheraphy for retinopathy of prematurity: ophthalmological outcomes at 10 years of age Arch Ophthalmol 2001;119:1110-1008
107. 2001 Contrast sensitivity at age 10 years in children who had threshold retinopathy of prematurity. Arch Ophthalmol 2001;119(8):1129-1133.
108. 2001 The Age-Related Eye Disease Study (AREDS) system for classifying cataracts from photographs: AREDS Report No. 4 Am J Ophthalmol 2001;131(2):167-175.
109. 2001 Risk factors associated with age-related nuclear and cortical cataract: a case-control study in the Age-Related Eye Disease Study, AREDS Report No. 5. Ophthalmology 2001;8:1400-1408.
110. 2001 Multicenter trial of cryotherapy for retinopathy of prematurity: ophthalmological outcomes at 10 years. Ophthalmol 2001;119:1110-1118.
111. 2001 Effect of retinal ablative therapy for threshold retinopathy of prematurity: results of Goldmann perimetry at the age of 10 years. Arch Ophthalmol 2001;119:1120-1125.
112. 2001 Contrast sensitivity at age 10 years in children who had threshold retinopathy of prematurity. Arch Ophthalmol 2001;119:1129-1133.
113. 2001 Cataract surgery by phacoemulsification in adults with retinopathy of prematurity. Am J Ophthalmol 2001;132:306-310.
114. 2001 Dietary fat and risk of advanced age-related macular degeneration. Arch Ophthalmol 2001;119:1191-1199.
115. 2001 A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS Report No. 8. Arch Ophthalmol 2001;119:1417-1436
116. 2001 A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss. AREDS Report No. 9. Arch Ophthalmol 2001;119:1439-1452.
117. 2001 The age-related eye disease study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: Report No. 6 Am J Ophthalmol 2001;132:668-681
118. 2001 Transscleral Diode Laser Retinopexy in the Treatment of Retinal Detachment Vitreoretinal Surgical Techniques, in Peyman GA, Meffert SA, Conway MD, Chou F (ed), Dunitz, London, England, 2001, pp. 27-31
119. 2001 Chorioretinal Biopsy, in Ryan SJ, Retina (3rd Edition), CV Mosby, St. Louis, 2001.
120. 2001 Cystoid Macular Edema, in Ryan SJ (ed), Retina (3rd edition), Mosby, St. Louis, 2001
121. 2000 Submacular surgery trials randomized pilot trial of laser versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration. II. Quality of life outcomes. Submacular Surgery Trials Pilot Study Report No. 2. Am J Ophthalmol 2000;130(4):408-418
122. 2000 Acute Annular Outer Retinopathy (AAOR): report of four cases. Am J Ophthalmol 2000;130:636-644
123. 2000 Perfluoroperhydrophenanthrene (Vitreon) versus perfluoro-n-octane (PFO) in vitreoretinal surgery Ophthalmology 2000;107(6):1078-1082
124. 2000 Surgical management of recurrent iris stromal cyst. Am J Ophthalmol 2000;130:122-123
125. 2000 Limited macular translocation for neovascular maculopathy. Seminars in Ophthalmol 2000;15: 81-87.
126. 2000 The Age-Related Eye Disease Study (AREDS): a clinical trial of zinc and antioxidants AREDS Report No. 2. J Nutr 2000;130:1516S-1519S.
127. 2000 Involution of retinopathy of prematurity Arch Ophthalmol 2000;118(5):645-649.
128. 2000 Risk factors associated with age-related macular degeneration: a case control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Am J Ophthalmol 2000;107(12):2224-2232.
129. 2000 Submacular surgery trials randomized pilot trial of laser versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration. I. Ophthalmic outcomes. Submacular Surgery Trials Pilot Study Report No. 1. Am J Ophthalmol 2000;130:387-407
130. 1999 Natural history study and clinical-design implications. AREDS Report Number 1. Controlled Clinical Trials 1999;20:573-600.
131. 1999 Histopathological features of vitreous removed at macular hole surgery. Arch Ophthalmol 1999;117:478-484.
132. 1999 North Carolina macular dystrophy (MCDR1) focus: a fine resolution genetic map and haplotype analysis Molecular Vision 1999;5:38
133. 1999 Clinical course of macular holes. Arch Ophthalmol 1999;117:242-246
134. 1999 Fungal retinitis and endophthalmitis Ophthalmol Clin NA 1999;12:89-108
135. 1998 Epidemiology and clinical characteristics of macular holes. Madreperla SA and McCuen B (ed) Macular Hole: Pathogenesis, Diagnosis and Treatment, Butterworth Heineman, New York, 1998, pp. 25-36
136. 1998 Vitrectomy for the anterior segment surgeon, in Gottsch JD, Stark WJ, Goldberg MF (eds) Atlas of Ocular Surgery, Mosby, St. Louis, 1998, pp. 358-369
137. 1998 Histopathologic and ultrastructural findings of surgically excised choroidal neovascularization Arch Ophthalmol 1998;116:745-749
138. 1998 The incidence of ophthalmologic interventions in children with birth weights less than 1251 grams Ophthalmology 1998;105:1621-1627.
139. 1998 Effect of scleral indentation on diode laser transscleral retinal photocoagulation Ophthal Surg Lasers 1998;29:658-662
140. 1998 . Transscleral diode laser retinopexy in retinal detachment surgery: results of a randomized trial Retina 1998;18: 399-404
141. 1998 Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion Ophthalmology 1998;105:765-771
142. 1998 Strabismus in premature infants in the first year of life. Arch Ophthalmol 1998;116:329-333
143. 1997 Cataract extraction after retinal detachment Curr Opinion Ophthalmol 1997;111:39-43.
144. 1997 Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration Arch Ophthalmol 1997;115:741-747
145. 1997 A new treatment for retinal detachment Rev Ophth 1997;1:120-122
146. 1997 Campochiaro PA. Management of endophthalmitis in a silicone oil-filled eye Retina 1997;17:507-509.
147. 1997 Multicenter trial of transscleral diode laser for retinopexy in retinal detachment surgery Trans Am Ophthalmol Soc 1997;95:221-230.
148. 1996 Visual acuity of eyes after vitrectomy for retinopathy of prematurity Ophthalmology 1996;103:595-600.
149. 1996 Multicenter trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol 1996;114:417-424
150. 1996 Early retinal vessel development and iris vessel dilatation as factors in retinopathy of prematurity Arch Ophthalmol 1996;114:150-154
151. 1996 Transvitreal endocyclophotocoagulation Trans Am Ophthalmol Soc 1996;94:589-676.
152. 1996 Five-year follow-up of fellow eyes of individuals with ocular histoplasmosis and unilateral extrafoveal and juxtafoveal choroidal neovascularization. Arch Ophthalmol 1996;114:677-688
153. 1996 Risk factors for central retinal vein occlusion Arch Ophthalmol 1996;114:545-554.
154. 1996 Visual field loss following vitreous surgery. Arch Ophthalmol 1996;114:564-569
155. 1996 Occult choroidal neovascularization: influence on visual outcome in patients with age-related macular degeneration Arch Ophthalmol 1996;114:400-412.
156. 1996 Phacoemulsification after retinal detachment surgery. Ophthalmology 1996;103:216-219
157. 1996 Early retinal vessel development and iris vessel dilatation as factors in retinopathy of prematurity Arch Ophthalmol 1996;114(92):150-154
158. 1996 Visual fields measured with double-arc perimetry in eyes with threshold retinopathy of prematurity from the cryotherapy of prematurity trial Ophthalmology 1996;103(9):1432-1437
159. 1995 Serum zinc and serum lipid profiles in 778 adults AEP 1995;5:490-496
160. 1995 Pseudophakic Candida parapsilosis endophthalmitis with a consecutive keratitis. Cornea 1995;14:212-216
161. 1995 Class III β-tubulin in human retinal pigment epithelial cells in culture and in epiretinal membranes Experimental Eye Res 1995;60:385-400
162. 1995 The influence of treatment extent on the visual acuity of eyes treated with krypton laser for juxtafoveal choroidal neovascularization. Arch Ophthalmol 1995;113:190-194
163. 1995 Laser photocoagulation for neovascular lesions nasal to the fovea. Arch Ophthalmol 1995;113:56-61.
164. 1995 An analysis of posterior segment complications after vitrectomy using the perfluorocarbon perfluoroperhydrophenanthrene (Vitreon). Ophthal Surg 1995;26:29-33
165. 1995 Comparison of recognition and grating acuities in very-low-birth-weight children with and without residua of retinopathy of prematurity Invest Ophthalmol Vis Sci 1995;36(3):692-702.
166. 1995 An unusual case of cryptococcal endophthalmitis Retina 1995;15:300-303
167. 1995 Grating visual acuity in eyes with retinal residua of retinopathy of prematurity. Arch Ophthalmol 1995;113:1172-1177.
168. 1994 Cavernous hemangioma of the optic nerve Retina 1994;14:359-361.
169. 1994 Effect of acute-phase retinopathy of prematurity on grating acuity development in the very low birth weight infant Invest Ophthalmol Vis Sci 1994;35: 4236-4244.
170. 1994 Repair of retinal detachment associated with proliferative vitreoretinopathy using perfluoroperhydrophenanthrene (Vitreon): Ca J Ophthalmol 1994;29:66-69.
171. 1994 Evaluation of argon green vs. krypton red laser for photocoagulation of subfoveal choroidal neovascularization in the Macular Photocoagulation Study. Arch Ophthalmol 1994;112:1176-1184
172. 1994 Secondary epiretinal membrane after blunt trauma. Maryland Medical J 1994;43(6):505-508.
173. 1994 Risk factors for idiopathic macular holes Am J Ophthalmol 1994;118:754-761.
174. 1994 Laser photocoagulation for juxtafoveal choroidal neovascularization. Arch Ophthalmol 1994;112:500-509.
175. 1994 Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Arch Ophthalmol 1994;112:489-499
176. 1994 Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol 1994;112:480-488
177. 1994 Dietary carotenoids, vitamins A, C and E and advanced age-related macular degeneration: A multicenter study JAMA 1994;272:1413-1420.
178. 1994 Improved visual results after surgical repair of cytomegalovirus-related detachments. Ophthalmology 1994;101:264-269
179. 1994 The eye in bone marrow transplantation: VI: retinal complications Arch Ophthalmol 1994;112:372-379.
180. 1994 Intraocular silicone oil: in vitro and in vivo MR and CT characteristics. Am J Neuroradiology 1994;15:343-347
181. 1993 Central serous chorioretinopathy and pregnancy Arch Ophthalmol 1993;111:360-364.
182. 1993 Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol 1993;111:104-109
183. 1993 Subfoveal neovascular lesions in age-related macular degeneration. Arch Ophthalmol 1993;111:104-109
184. 1993 Prognostic factors in the natural course of retinopathy of prematurity. Ophthalmology 1993;100(2):230-237
185. 1993 Prediction of visual function in eyes with mild to moderate posterior pole residua of retinopathy of prematurity. Arch Ophthalmol 1993;111:1050-1056
186. 1993 Multicenter trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol 1993;111:339-344
187. 1993 Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration: updated findings from two clinical trials. Arch Ophthalmol 1993;111:1200-1209
188. 1993 Five year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Arch Ophthalmol 1993;111:1189-1199
189. 1993 A new syndrome of myelinated nerve fibers, vitreoretinopathy, and skeletal malformations Arch Ophthalmol 1993;111: 1543-1545
190. 1993 Risk factors for branch retinal vein occlusion Am J Ophthalmol 1993;116:286-296.
191. 1993 Vitrectomy for persistent vitreous hemorrhage from a cavernous hemangioma of the optic disc Am J Ophthalmol 1993;116:106-107
192. 1993 Risk factors for idiopathic rhegmatogenous retinal detachment. Am J Epidemiology 1993;137:749-757.
193. 1993 Pilot trial of transscleral diode laser retinopexy in retinal detachment surgery. Arch Ophthalmol 1993;111:952-956
194. 1993 Multicenter trial of cryotherapy for retinopathy of prematurity: 32 year outcome, structure and function Arch Ophthalmol 1993;111:339-344.
195. 1992 Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 1992;110:1701-1708
196. 1992 Acute Retinal Necrosis Current Practice in Ophthalmology, CV Mosby, St. Louis, 1992, pp. 333-344.
197. 1992 Posterior chamber IOL implantation without capsular support. Current Practice in Ophthalmology, CV Mosby, St. Louis, 1992, pp.125-143
198. 1992 Late-onset sterile endophthalmitis following tube implant surgery. Am J Ophthalmol 1992;114:771-772
199. 1992 Chronic postoperative rhodotorula endophthalmitis Arch Ophthalmol 1992;110:1686-1687.
200. 1991 Argon laser photocoagulation for neovascular maculopathy after five years. Results from randomized clinical trials Arch Ophthalmol 1991;109:1109-1114.
201. 1991 Operational aspects of terminating randomization in the multicenter trial of cryotherapy of retinopathy of prematurity Control Clin Trials 1991; 12(2):277-292.
202. 1991 Statistical considerations in terminating randomization in the multicenter trial of cryotherapy for retinopathy of prematurity Control Clin Trials 1991;12(2):293-303.
203. 1991 Loculated fluid: a previously undescribed fluorescein angiographic finding in choroidal neovascularization associated with macular degeneration. Arch Ophthalmol 1991;109:211-215
204. 1991 Pretreatment fundus characteristics as predictors of recurrent choroidal neovascularization. Arch Ophthalmol 1991;109:1193-1194
205. 1991 Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration Arch Ophthalmol 1991;109:614-615
206. 1991 Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the Macular Photocoagulation Study. Arch Ophthalmol 1991;109:1242-1257.
207. 1991 Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 1991;109:1232-1241
208. 1991 Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 1991;109:1220-1231
209. 1991 Retinal detachment in patients with cytomegalovirus retinitis. Arch Ophthalmol 1991;109:794-799
210. 1990 Evaluation of an iris color classification system Inv Ophthal Vis Sci 1990;31:1592-1598
211. 1990 Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration Arch Ophthalmol 1990;108:1442-1447.
212. 1990 Choroidal neovascularization after laser photocoagulation for diabetic macular edema. Ophthalmology 1990;97:503-511
213. 1990 Krypton laser photocoagulation for idiopathic neovascular lesions. Arch Ophthalmol 1990;108:832-837
214. 1990 Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of age-related macular degeneration Arch Ophthalmol 1990;108:825-831.
215. 1990 Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol 1990;108:816-824
216. 1989 Reproducibility of refraction and visual acuity measurement under a standard protocol Retina 1989;9:163-169
217. 1989 Persistent and recurrent neovascularization after Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis Arch Ophthalmol 1989;107:344-352
218. 1989 The use of fundus photographs and fluorescein angiograms in the identification and treatment of choroidal neovascularization in the Macular Photocoagulation Study Ophthalmology 1989;96:1526-1534
219. 1989 Coats’ Disease Ryan SJ (ed), Retina (1st edition), CV Mosby, St. Louis, 1989, pp.1453-1460.
220. 1989 The rate of sulfur hexafluoride escape from a plastic syringe. Arch Ophthalmol 1989;107:853-854
221. 1988 Photocoagulation to prevent retinal detachment in acute retinal necrosis. Ophthalmology 1988;95:1389-1393.
222. 1988 Interphotoreceptor retinoid-binding protein (IRBP) levels in subretinal fluid from rhegmatogenous retinal detachment and retinopathy of prematurity Arch Ophthalmol 1988;106:106-110.
223. 1988 Retinal pigment epithelial tears: patterns and prognosis Ophthalmology 1988;95:8-13.
224. 1987 Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Results of randomized clinical trial Arch Ophthalmol 1987;105:1499-1507.
225. 1987 Silicone oil in the treatment of complicated retinal detachments. Ophthalmology 1987;94:1109-1113
226. 1987 Conjunctival pigmentation following pars plana vitrectomy. Retina 1987;7:38-40
227. 1986 Oral colchicine for the treatment of experimental traction retinal detachment. Arch Ophthalmol 1986;104:1226-1229
228. 1986 Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy Arch Ophthalmol 1986;104: 503-512.
229. 1986 Acute retinal necrosis (ARN) syndrome following herpes zoster dermatitis. Ophthalmology 1986;93:1418-1422
230. 1986 Extension of retinal detachments as a complication of pneumatic retinopexy. Arch Ophthalmol 1986;104:1161-1163
231. 1986 Potential acuity meter for predicting visual acuity after Nd: YAG posterior capsulotomy Ophthalmology 1986; 93:397-400
232. 1986 Intravitreous fibronectin and platelet-derived growth factor: new model for traction retinal detachments Arch Ophthalmol 1986;104:417-421.
233. 1985 Preoperative laser photocoagulation to mark tiny retinal breaks in eyes with retinal detachment. Retina 1985;3:161-162
234. 1985 Pathologic features of senile macular degeneration Ophthalmology 1985;92:615-627
235. 1985 Dehiscences of the pigment epithelium Tr Am Ophth Soc 1985;83:63-81.
236. 1985 Argon laser debridement of the posterior capsule: a potential treatment for posterior capsule opacification after extracapsular cataract surgery Ophthal Surg 1985;16:549-551
237. 1984 Using eye signs to detect systemic disease Contemporary Ob/Gyn 1984;10:191-200.
238. 1983 The ultrastructure of an IOL “Cocoon Membrane.” Ophthalmology 1983;90:410-419
239. 1983 Opportunistic toxoplasmic retinochoroiditis following chemotherapy to systemic lymphoma: a light and electron microscopic study. Ophthalmology 1983;90:885-898
240. 1983 Metastatic carcinoma masquerading as scleritis. Ophthalmology 1983;90:184-194
241. 1982 Combined clinical and computed tomographic diagnosis of orbital lymphoid tumors. Am J Ophthalmol 1982;94:235-245
242. 1982 Combined clinical and computed tomographic diagnosis of primary lacrimal fossa lesions. Am J Ophthalmol 1982;94:785-807
243. 1981 Choroidal neovascularization as a late complication of ocular toxoplasmosis. Am J Ophthalmol 1981;91:318-322


About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.